ArticleiScience2024

CRISPR-Cas9 screening identifies INTS3 as an anti-apoptotic RNA-binding protein and therapeutic target for colorectal cancer.

Zhiwei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.